Opioid and benzodiazepine withdrawal syndromes in the paediatric intensive care unit: A review of recent literature

Nursing in Critical Care

Volumn 14, Issue 1, 2009, Pages 26-37

  Birchley, Giles ^a  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

Benzodiazepines; Dependence; Opioids; Paediatric intensive care unit; Tolerance; Withdrawal symptoms

Indexed keywords

BENZODIAZEPINE DERIVATIVE; NARCOTIC ANALGESIC AGENT;

CHILD; CONSCIOUS SEDATION; DRUG MONITORING; HUMAN; IATROGENIC DISEASE; INCIDENCE; INTENSIVE CARE; INTENSIVE CARE UNIT; METHODOLOGY; NURSING; NURSING ASSESSMENT; NURSING RESEARCH; PEDIATRIC NURSING; PREVALENCE; REVIEW; RISK FACTOR; WITHDRAWAL SYNDROME;

ANALGESICS, OPIOID; BENZODIAZEPINES; CHILD; CONSCIOUS SEDATION; DRUG MONITORING; HUMANS; IATROGENIC DISEASE; INCIDENCE; INTENSIVE CARE; INTENSIVE CARE UNITS, PEDIATRIC; NURSING ASSESSMENT; NURSING RESEARCH; PEDIATRIC NURSING; PREVALENCE; RESEARCH DESIGN; RISK FACTORS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 65549139460     PISSN: 13621017     EISSN: 14785153     Source Type: Journal    
DOI: 10.1111/j.1478-5153.2008.00311.x     Document Type: Review

References (61)

1. American Academy of Pediatrics – Committee on Drugs. (1998). Neonatal drug withdrawal. Pediatrics; 101: 1079–1088. http://www.pediatrics.org/cgi/content/full/101/6/1079 (accessed 6/08/08).
2. Arnold J, Truog R, Orav E, Scavone J, Hershenson M. (1990). Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology; 73: 1136–1140.
3. Atack J. (2003). Anxioselective compounds acting at the GABAA receptor benzodiazepine binding site. Current Drug Targets. CNS and Neurological Disorders; 2: 213–232.
4. Bailey C, Connor M. (2005). Opioids: cellular mechanisms of tolerance and physical dependence. Current Opinion in Pharmacology; 5: 60–68.
5. Bailey E, Timmons S. (2005). Noise levels in PICU: an evaluative study. Paediatric Nursing; 17: 22–26.
6. Bateson A. (2002). Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Current Pharma-ceutical Design; 8: 5–21.
7. Berens R, Meyer M, Mikhailov T, Colpaert K, Czarnecki M, Ghanayem N, Hoffman G, Soetenga D, Nelson T, Weisman W. (2006). A prospective evaluation of opioid weaning in opioid dependent pediatric critical care patients. Anesthetic Analgesia; 102: 1045–1050.
8. Bergman I, Steeves M, Burckart G, Thompson A. (1991). Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. Journal of Pediatrics; 119: 644–649.
9. Biswas A, Feldman B, Davis D, Zietz E. (2005). Myocardial ischemia as a result of severe benzodiazepine and opioid withdrawal. Clinical Toxicology; 43: 207–209.
10. Carnevale F, Ducharme C. (1997). Adverse reactions to the withdrawal of opioids and benzodiazepines in paediatric intensive care. Intensive & Critical Care Nursing; 13: 181–188.
11. Carr D. (1994). Fentanyl infusion and weaning in the pediatric intensive care unit: towards science based practice. Critical Care Medicine; 22: 725–727.
12. Casy A, Parfitt R. (1986). Opioid Analgesics. New York: Plenum Press.
13. Cho H, O’Connell J, Cooney M, Inchiosa J. (2007). Minimizing tolerance and withdrawal to prolonged pediatric sedation: case report and review of the literature. Journal of Intensive Care Medicine; 22: 173–179.
14. Colville G, Kerry S, Pierce C. (2008). Children’s factual and delusional memories of intensive care. American Journal of Respiratory and Critical Care Medicine; 177: 976–982.
15. Corbett A, Henderson G, McKnight A, Paterson S. (2006). 75 years of opioid research: the exciting but vain quest for the holy grail. British Journal of Pharmacology; 147: S153–S162.
16. Cormack D. (1991). The Research Process in Nursing. 2nd edn. Oxford: Blackwell Publishing.
17. Cunliffe M, McArthur L, Dooley F. (2004). Managing sedation withdrawal in children who undergo prolonged PICU admission after discharge to the ward. Pediatric Anesthesia; 14: 293–298.
18. Deutsch E, Nadkarni V. (1996). Clonidine prophylaxis for narcotic and sedative withdrawal syndrome following laryngotracheal reconstruction. Archives of Otolaryngology – Head & Neck Surgery; 122: 1234–1238.
19. Dominguez K, Lomako D, Katz R, Kelly H. (2003). Opioid withdrawal in critically ill neonates. The Annals of Pharmacotherapy; 37: 473–477.
20. Ducharme C, Carnevale F, Clermont M. (2005). A prospective study of adverse reactions to the weaning of opioids and benzodiazepines among critically ill children. Intensive & Critical Care Nursing; 21: 179–186.
21. Ducharme M, Munzenberger P. (1995). Severe withdrawal syndrome possibly associated with cessation of a midazolam and fentanyl infusion. Pharmacotherapy; 15: 665–668.
22. Finnegan L, Connaughton J, Kron R, Emich J. (1975). Neonatal abstinence syndrome: assessment and management. Addictive Diseases; 2: 141–158.
23. Fonsmark L, Rasmussen Y, Carl, P. (1999). Occurrence of withdrawal in critically ill sedated children. Critical Care Medicine; 27: 196–199.
24. Franck L, Naughton I, Winter I. (2004). Opioid and benzodiaz-epine withdrawal symptoms in paediatric intensive care patients. Intensive & Critical Care Nursing; 20: 344–351.
25. Franck L, Vilardi J, Durand D, Powers R. (1998). Opioid withdrawal in neonates after continuous infusions of morphine or fentanyl during extracorporeal membrane oxygenation. American Journal of Critical Care; 7: 364–369.
26. Gerrish K, Lacey A. (2006). The Research Process in Nursing, 5th edn. Oxford: Blackwell Publishing.
27. Ista E, van Dijk M, Gamel C, Tibboel D, de Hoog M. (2007). Withdrawal symptoms in children after long-term administration of sedatives and/or analgesics: a literature review. ‘‘Assessment remains troublesome’’. Intensive Care Medicine; 33: 1396–1406.
28. Ito H, Sobue K, Hirate H, Sugiura T, So M, Azami T, Sasano H, Katsuya H. (2006). Use of ketamine to facilitate opioid withdrawal in a child. Anesthesiology; 104: 1113.
29. Jacobs B, Salman B, Cotton R, Lyons K, Brilli R. (2001). Postoperative management of children after single-stage laryngotracheal reconstruction. Critical Care Medicine; 29: 164–168.
30. Jenkins I, Playfor I, Bevan C, Davies G, Wolf A. (2007). Current United Kingdom sedation practice in pediatric intensive care. Pediatric Anaesthesia; 17: 675–684.
31. Katz R, Kelly H. (1993). Pharmacokinetics of continuous infusions of fentanyl in critically ill children. Critical Care Medicine; 21: 995–1000.
32. Katz R, Kelly H, Hsi A. (1994). A prospective study on the occurrence of withdrawal in critically ill children who receive fentanyl by continuous infusion. Critical Care Medicine; 22: 763–767.
33. Lugo R, Lee W, Cash J, Vernon D, Ward R. (2003). Opioid abstinence syndrome in the PICU: frequency of signs, 12th Annual Abstracts. Journal of Paediatric Pharmacological Therapy; 8: 232–233.
34. Lugo R, MacLaren R, Cash J, Pribble C, Vernon D. (2001). Enteral methadone to expedite fentanyl discontinuation and prevent opioid abstinence syndrome in the PICU. Pharmacotherapy; 21: 1566–1573.
35. Lugo R, Satterfield K, Kern S. (2005). Pharmacokinetics of methadone. Journal of Pain & Palliative Care Pharmacotherapy; 19: 13–24.
36. Martin L, Bratton S, Quint P, Mayock D. (2001). Prospective documentation of sedative, analgesic, and neuromuscular blocking agent use in infants and children in the intensive care unit: a multicenter perspective. Pediatric Critical Care Medicine; 2: 205–210.
37. Meyer M, Berens R. (2001). Efficacy of an enteral 10-day methadone wean to prevent opioid withdrawal in fentanyl-tolerant pediatric intensive care unit patients. Pediatric Critical Care Medicine; 2: 329–333.
38. Nichols D. (2004). The PICU nightmare. Pediatric Critical Care Medicine; 5: 411–412.
39. Ostrea E, Chavez C, Strauss M. (1975). A study of factors that influence the severity of neonatal narcotic withdrawal. Addictive Diseases; 2(1-2): 187–199.
40. Playfor S, Jenkins I, Boyles C, Choonara I, Davies G, Haywood T, Hinson G, Mayer A, Morton N, Ralph T, Wolf A. (2006). Consensus guidelines on sedation and analgesia in critically ill children. Intensive Care Medicine; 32: 1125–1136.
41. Playfor S, Thomas D, Choonara I. (2003). Sedation and neuromuscular blockade in paediatric intensive care: a review of current practice in the UK. Paediatric Anaesthesia; 13: 147–151.
42. Rhoney D, Murray K. (2002). National survey on the use of sedatives and neuromuscular blocking agents in the pediatric intensive care unit. Pediatric Critical Care Medicine; 3: 129–133.
43. Robertson R, Darsey E, Fortenberry J, Pettignano R, Hartley G. (2000). Evaluation of an opiate-weaning protocol using methadone in pediatric intensive care patients. Pediatric Critical Care Medicine; 1: 119–123.
44. Rosen D. (2005). Medications to provide cooperation in the critically ill pediatric patient: a rose with a thorn. Critical Care Medicine; 33: 2141–2143.
45. Sarkar S, Donn S. (2006). Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey. Journal of Perinatology; 26: 5–17.
46. Sfoggia A, Fontela P, Moraes A, de Silva F, Sober R, Noer R, Bruno F, Einloft P, Garcia P, Piva J. (2003). Sedation and analgesia in children submitted to mechanical ven-tilation could be overestimated? Jornal de Pediatria; 79: 343–348.
47. Siddappa R, Fletcher J, Heard A, Kielma D, Cimino M, Heard C. (2003). Methadone dosage for prevention of opioid withdrawal in children. Paediatric Anaesthesia; 13: 805–810.
48. Sorce L. (2005). Adverse responses: sedation, analgesia and neuromuscular blocking agents in critically ill children. Critical Care Nursing Clinics of North America; 17: 441–450.
49. Sury M, Russell G, Hopkins C, Thornington R, Vivori E. (1989). Acute benzodiazepine withdrawal syndrome after midazo-lam infusions in children. Critical Care Medicine; 17: 301–302.
50. Treiman D. (1989). Pharmacokinetics and clinical use of benzodiazepines in the management of status epilepticus. Epilepsia; 30 (Suppl. 2); S4–S10.
51. Tobias J. (1999). Subcutaneous administration of fentanyl and midazolam to prevent withdrawal after prolonged sedation in children. Critical Care Medicine; 27: 2262–2265.
52. Tobias J. (2000). Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Critical Care Medicine; 28: 2122–2132.
53. Tobias J. (2006). Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU. Journal of Opioid Management; 2: 201–205.
54. Tobias J, Berkenbosch J, Russo P. (2003). Additional experience with dexmedetomidine in pediatric patients. Southern Medical Journal; 96: 871–875.
55. Tobias J, Deshpande J, Gregory D. (1994). Outpatient therapy of iatrogenic drug dependency following prolonged sedation in the pediatric intensive care unit. Intensive Care Medicine; 20: 504–507.
56. Van Engelen B, Gimbrere J, Booy L. (1993). Benzodiazepine withdrawal reaction in two children following discontinuation of sedation with midazolam. Annals of Pharmacotherapy; 27: 579–581.
57. Wheeler A, Bothwell M, Tobias J. (2005). Prevention of medication withdrawal following laryngotracheoplasty. American Journal of Pain Management; 15: 15–21.
58. Wheeler A, Tobias J. (2006). Bradycardia during methadone therapy in an infant. Pediatric Critical Care Medicine; 7: 83–85.
59. de Wildt S, de Hoog M, Vinks A, Joosten K, van Dijk M, van den Anker J. (2005). Pharmacodynamics of midazolam in pediatric intensive care patients. Therapeutic Drug Monitoring; 27: 98–102.
60. Yaster M, Kost-Byerly S, Berde C, Billet C. (1996). The management of opioid and benzodiazepine dependence in infants, children, and adolescents. Pediatrics; 98: 135–140.
61. Zapantis A, Leung S. (2005). Tolerance and withdrawal issues with sedation. Critical Care Nursing Clinics of North America; 17: 211–223.